During the past decade, NeuroCare, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 11 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NeuroCare, Inc." #1 sponsor was "Jazz Pharmaceuticals" with 4 trials, followed by "Cephalon" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Harmony Biosciences, LLC" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NeuroCare, Inc." #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Ortho-McNeil Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "NeuroCare, Inc." are "Narcolepsy" (5 trials), "Alzheimer's Disease" (4 trials), "Excessive Daytime Sleepiness" (3 trials), "Idiopathic Hypersomnia" (3 trials) and "Insomnia" (3 trials). Many other conditions were trialed in "NeuroCare, Inc." in a lesser frequency.

Most popular intervention types in "NeuroCare, Inc." are "Drug" (24 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "JZP-110" (3 trials), "Placebo oral tablet" (3 trials), "Armodafinil" (2 trials) and "Bapineuzumab 0.5 mg/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "NeuroCare, Inc." are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NeuroCare, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in NeuroCare, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in NeuroCare, Inc., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".